Cargando…

Botulinum Toxin Physiology in Focal Hand and Cranial Dystonia

The safety and efficacy of botulinum toxin for the treatment of focal hand and cranial dystonias are well-established. Studies of these adult-onset focal dystonias reveal both shared features, such as the dystonic phenotype of muscle hyperactivity and overflow muscle contraction and divergent featur...

Descripción completa

Detalles Bibliográficos
Autor principal: Karp, Barbara Illowsky
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509715/
https://www.ncbi.nlm.nih.gov/pubmed/23202323
http://dx.doi.org/10.3390/toxins4111404
_version_ 1782251391253741568
author Karp, Barbara Illowsky
author_facet Karp, Barbara Illowsky
author_sort Karp, Barbara Illowsky
collection PubMed
description The safety and efficacy of botulinum toxin for the treatment of focal hand and cranial dystonias are well-established. Studies of these adult-onset focal dystonias reveal both shared features, such as the dystonic phenotype of muscle hyperactivity and overflow muscle contraction and divergent features, such as task specificity in focal hand dystonia which is not a common feature of cranial dystonia. The physiologic effects of botulinum toxin in these 2 disorders also show both similarities and differences. This paper compares and contrasts the physiology of focal hand and cranial dystonias and of botulinum toxin in the management of these disorders.
format Online
Article
Text
id pubmed-3509715
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-35097152012-12-10 Botulinum Toxin Physiology in Focal Hand and Cranial Dystonia Karp, Barbara Illowsky Toxins (Basel) Review The safety and efficacy of botulinum toxin for the treatment of focal hand and cranial dystonias are well-established. Studies of these adult-onset focal dystonias reveal both shared features, such as the dystonic phenotype of muscle hyperactivity and overflow muscle contraction and divergent features, such as task specificity in focal hand dystonia which is not a common feature of cranial dystonia. The physiologic effects of botulinum toxin in these 2 disorders also show both similarities and differences. This paper compares and contrasts the physiology of focal hand and cranial dystonias and of botulinum toxin in the management of these disorders. MDPI 2012-11-20 /pmc/articles/PMC3509715/ /pubmed/23202323 http://dx.doi.org/10.3390/toxins4111404 Text en The author is an employee of the U.S. National Institutes of Health (“NIH”), and the article is a U.S. Government Work, published by MDPI, Basel, Switzerland, with the permission of NIH. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Karp, Barbara Illowsky
Botulinum Toxin Physiology in Focal Hand and Cranial Dystonia
title Botulinum Toxin Physiology in Focal Hand and Cranial Dystonia
title_full Botulinum Toxin Physiology in Focal Hand and Cranial Dystonia
title_fullStr Botulinum Toxin Physiology in Focal Hand and Cranial Dystonia
title_full_unstemmed Botulinum Toxin Physiology in Focal Hand and Cranial Dystonia
title_short Botulinum Toxin Physiology in Focal Hand and Cranial Dystonia
title_sort botulinum toxin physiology in focal hand and cranial dystonia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509715/
https://www.ncbi.nlm.nih.gov/pubmed/23202323
http://dx.doi.org/10.3390/toxins4111404
work_keys_str_mv AT karpbarbaraillowsky botulinumtoxinphysiologyinfocalhandandcranialdystonia